Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.
Guadalupi L, Vanni V, Balletta S, Caioli S, De Vito F, Fresegna D, Sanna K, Nencini M, Donninelli G, Volpe E, Mariani F, Battistini L, Stampanoni Bassi M, Gilio L, Bruno A, Dolcetti E, Buttari F, Mandolesi G, Centonze D, Musella A. Guadalupi L, et al. Among authors: musella a. J Neuroinflammation. 2024 May 14;21(1):128. doi: 10.1186/s12974-024-03120-9. J Neuroinflammation. 2024. PMID: 38745307 Free PMC article.
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Di Caprio V, Lauritano G, Borrelli A, Galifi G, Furlan R, Finardi A, Musella A, Guadalupi L, Mandolesi G, Rovella V, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: musella a. Front Neurol. 2024 Feb 23;15:1326506. doi: 10.3389/fneur.2024.1326506. eCollection 2024. Front Neurol. 2024. PMID: 38585351 Free PMC article.
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A. Guadalupi L, et al. Among authors: musella a. Neuropharmacology. 2024 Jul 1;252:109940. doi: 10.1016/j.neuropharm.2024.109940. Epub 2024 Apr 2. Neuropharmacology. 2024. PMID: 38570068 Free article.
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.
Palaia I, Caruso G, Di Donato V, Turetta C, Savarese A, Perniola G, Gallo R, Giannini A, Salutari V, Bogani G, Tomao F, Giannarelli D, Gentile G, Musella A, Muzii L, Pignata S; MITO group. Palaia I, et al. Among authors: musella a. J Gynecol Oncol. 2024 May;35(3):e70. doi: 10.3802/jgo.2024.35.e70. Epub 2024 Mar 4. J Gynecol Oncol. 2024. PMID: 38497108 Free PMC article.
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation.
Stampanoni Bassi M, Gilio L, Galifi G, Buttari F, Dolcetti E, Bruno A, Belli L, Modugno N, Furlan R, Finardi A, Mandolesi G, Musella A, Centonze D, Olivola E. Stampanoni Bassi M, et al. Among authors: musella a. Parkinsonism Relat Disord. 2024 May;122:106071. doi: 10.1016/j.parkreldis.2024.106071. Epub 2024 Feb 28. Parkinsonism Relat Disord. 2024. PMID: 38432021 Free article.
Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study.
Galli V, Golia D'Augè T, DI Pierro F, Cazzaniga M, Guasti L, Zerbinati N, Bertuccioli A, Khan A, D'Ovidio G, Iaculli F, Tibaldi V, Santangelo G, Fischetti M, Casorelli AF, DI Donato V, Giannini A, Musella A, Giancotti A, Monti M. Galli V, et al. Among authors: musella a. Minerva Obstet Gynecol. 2024 Feb 15. doi: 10.23736/S2724-606X.23.05409-X. Online ahead of print. Minerva Obstet Gynecol. 2024. PMID: 38358384 Free article.
Primary neuroendocrine neoplasms of the vulva: A review of the MITO rare cancer group.
Barcellini A, Golia D'Augè T, Mandato VD, Cuccu I, Musella A, Fruscio R, Vitale MG, Martinello R, Mangili G, Pignata S, Palaia I. Barcellini A, et al. Among authors: musella a. Crit Rev Oncol Hematol. 2024 Jan;193:104201. doi: 10.1016/j.critrevonc.2023.104201. Epub 2023 Nov 17. Crit Rev Oncol Hematol. 2024. PMID: 37977312 Free article. Review.
Iodized Salt May Not Be Sufficient to Guarantee an Adequate Iodine Intake in Pregnant Women.
Spina V, Baldini E, Cardarelli S, Oliva C, Venarubea S, Faraoni F, Pastore G, Tittoni R, Musella A, Squarcella A, Lori E, Renzi E, Feroci R, Mastrodonato F, Ciferri F, Virili C, Centanni M, Fabiani C, Rago R, Schiavi MC, Palazzetti P, D'Armiento E, Cantisani V, Sorrenti S, Ulisse S. Spina V, et al. Among authors: musella a. Nutrients. 2023 Sep 27;15(19):4182. doi: 10.3390/nu15194182. Nutrients. 2023. PMID: 37836466 Free PMC article.
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis.
Stampanoni Bassi M, Gilio L, Buttari F, Dolcetti E, Bruno A, Galifi G, Azzolini F, Borrelli A, Mandolesi G, Gentile A, De Vito F, Musella A, Simonelli I, Centonze D, Iezzi E. Stampanoni Bassi M, et al. Among authors: musella a. Eur J Neurol. 2024 Mar;31(3):e16071. doi: 10.1111/ene.16071. Epub 2023 Sep 27. Eur J Neurol. 2024. PMID: 37754770
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Bruno A, Buttari F, Dolcetti E, Azzolini F, Borrelli A, Lauritano G, Di Caprio V, Rizzo FR, Gilio L, Galifi G, Furlan R, Finardi A, Guadalupi L, Musella A, Mandolesi G, Centonze D, Stampanoni Bassi M. Bruno A, et al. Among authors: musella a. Mult Scler. 2023 Oct;29(11-12):1383-1392. doi: 10.1177/13524585231197928. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37698019
183 results